Akwai rahotannin barkewar cutar Human Metapneumovirus (hMPV) a sassa da yawa na duniya. A cikin yanayin cutar ta COVID-19 na baya-bayan nan, barkewar hMPV a cikin ƙasashe da yawa na haifar da damuwa a tsakanin mutane. Duk da haka, karuwar da aka gani a cikin ...
Concizumab (sunan kasuwanci, Alhemo), FDA ta amince da maganin monoclonal a ranar 20 ga Disamba 2024 don rigakafin cututtukan jini a cikin marasa lafiya tare da hemophilia A tare da masu hana factor VIII ko hemophilia B tare da masu hana factor IX. Ya kasance ...
Cutar tarin fuka mai jure wa miyagun ƙwayoyi (MDR TB) tana shafar mutane rabin miliyan kowace shekara. Ana ba da shawarar Levofloxacin don rigakafin rigakafi bisa ga bayanan lura, duk da haka babu wata shaida daga babban gwajin asibiti. TB CHAMP da V-QUIN, kashi biyu na 3 na asibiti ...
An amince da Ryoncil don maganin cututtukan ƙwayar cuta mai saurin kamuwa da cuta (SR-aGVHD), yanayin barazanar rai wanda zai iya haifar da dashen sel na jini wanda aka yi don maye gurbin ɓangarorin sel na mai karɓa a cikin wasu nau'ikan cututtukan daji na jini. , ciwon jini...
Wani bincike na baya-bayan nan ya yi kiyasin yawan cututtuka na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da kuma cututtukan cututtukan da ke haifar da kamuwa da cutar ta GUD. Alkaluman sun nuna cewa kimanin mutane miliyan 846 masu shekaru 15-49 ne ke dauke da cututtukan al'aura a cikin 2020, wanda shine ...
Masu bincike sun kirkiro gwajin fitsari wanda zai iya gano ciwon huhu a farkon mataki ta hanyar amfani da sabon salo. Yana amfani da binciken furotin da za'a iya allura don gano kasancewar sel masu hankali a cikin huhu ko da yake suna hulɗa da ...
A ranar 22 ga Oktoba, 2024, wata tawagar tiyata ta yi aikin dashen huhun mutum biyu na mutum-mutumi na farko a kan wata mace mai shekaru 57 da ke fama da cutar huhu (COPD) ta amfani da tsarin mutum-mutumi na Da Vinci Xi a kowane mataki. Hanya mafi ƙanƙanci...
An yarda da Asciminib (Scemblix) ga marasa lafiya marasa lafiya tare da sabon bincike na Philadelphia chromosome-positive myeloid leukemia (Ph + CML) a cikin lokaci na yau da kullum (CP). FDA ta ba da izinin haɓakawa akan 29 Oktoba 2024. Tun da farko, FDA ta amince da asciminib...
A ranar 11 ga Oktoba, 2024, Hympavzi (marstacimab-hncq), wani ɗan adam monoclonal antibody wanda ke niyya “mai hana ƙwayar ƙwayar cuta” ta sami amincewar FDA ta Amurka a matsayin sabon magani don rigakafin cututtukan jini a cikin mutanen da ke da hemophilia A ko hemophilia B. Tun da farko, a ranar 19 ga Satumba. ...
Cobenfy (wanda aka fi sani da KarXT), haɗin magungunan xanomeline da trospium chloride, an yi nazari don yin tasiri don maganin schizophrenia kuma FDA ta amince da shi a matsayin antipsychotic a watan Satumba 20241. Wannan ...
BNT116 da LungVax 'yan takarar rigakafin cutar kansar huhun nucleic acid ne - tsohon ya dogara ne akan fasahar mRNA mai kama da "alurar rigakafin COVID-19 mRNA" kamar BNT162b2 na Pfizer/BioNTech da Moderna's mRNA-1273 yayin da maganin LungVax yayi kama da Oxford/AstraZeneca. ..
Monoclonal antibodies (mAbs) lecanemab da donanemab an amince da su don maganin farkon cutar Alzheimer a cikin Burtaniya da Amurka bi da bi yayin da lecanemab aka ƙi ba da izinin tallace-tallace a cikin EU saboda “rashin gamsuwa” aminci da inganci.
Kwayar cutar kyandar biri (MPXV), wacce ake kira haka saboda ganowarta ta farko a cikin birai da aka ajiye a wurin bincike a kasar Denmark, tana da alaka ta kut-da-kut da kwayar cutar variola da ke haifar da kananan yara. Ita ce ke da alhakin kamuwa da cutar kyandar biri da ta bulla a hankali...
Haɓaka na mpox a Jamhuriyar Demokradiyyar Kongo (DRC) da kuma a yawancin ƙasashe na Afirka WHO ta ƙaddara don zama gaggawar lafiyar jama'a na damuwa na duniya (PHEIC) a ƙarƙashin Dokokin Kiwon Lafiya na Duniya.
Bisa la'akari da mummunar barkewar cutar kyandar biri (Mpox) a Jamhuriyar Demokradiyyar Kongo (DRC) da yanzu ta bazu a wajen kasar da kuma gano sabon nau'in da ya fara bulla a watan Satumban 2023 a wajen DRC,...
Neffy (epinephrine nasal spray) FDA ta amince da ita don maganin gaggawa na nau'in rashin lafiyar Nau'in I ciki har da anaphylaxis mai barazanar rai. Wannan yana ba da madadin hanyar gudanar da epinephrine ga waɗanda (musamman yara) ƙin allura da ...
Tecelra (afamitresgene autoleucel), maganin kwayoyin halitta don kula da manya tare da sarcoma mestastatic synovial sarcoma an amince da ita ta FDA. Amincewar ta dogara ne akan kimanta aminci da inganci a cikin cibiyar da yawa, gwajin gwaji na asibiti. Yana...
Magungunan rigakafi na yanzu da ake amfani da su a aikin asibiti, baya ga kawar da ƙwayoyin cuta masu cutarwa kuma suna cutar da ƙwayoyin cuta masu lafiya a cikin hanji. Rashin damuwa a cikin microbiome na gut yana da tasiri mai guba akan hanta, koda da sauran gabobin. Wannan lamari ne da za a magance shi....
Wani bincike da aka yi kan bullar cutar sankarar biri (MPXV) da ta bulla a watan Oktoban shekarar 2023 a yankin Kamituga na Jamhuriyar Dimokaradiyyar Kongo (DRC) ya nuna cewa jima'i wata hanya ce ta yada kamuwa da cuta. Wannan...
Magungunan ƙwayoyin cuta na cephalosporin na ƙarni na biyar, Zevtera (Ceftobiprole medocaril sodium Inj.) FDA1 ta amince da shi don maganin cututtuka guda uku. Staphylococcus aureus cututtuka na jini (bacteremia) (SAB), ciki har da wadanda ke da ciwon endocarditis na gefen dama; m kwayoyin cuta fata da fata tsarin cututtuka (ABSSSI);...
Rezdiffra (resmetirom) FDA ta Amurka ta amince da ita don kula da manya masu fama da ciwon steatohepatitis maras-giya (NASH) tare da matsakaici zuwa ci-gaba na hanta (fibrosis), don amfani da abinci tare da motsa jiki. Har yanzu, marasa lafiya da ...
Hukumar Lafiya ta Duniya (WHO) ta wallafa wani sabon bayani, cikakkiyar jagorar bincike don tabin hankali, ɗabi'a, da rikice-rikicen ci gaban jijiya. Wannan zai taimaka wa ƙwararrun lafiyar hankali da sauran ƙwararrun ƙwararrun kiwon lafiya don ganowa da gano cututtukan ƙwaƙwalwa, ɗabi'a da ci gaban neurodevelopment a cikin saitunan asibiti ...
A cikin Fabrairu 2024, kasashe biyar a cikin WHO Turai yankin (Austria, Denmark, Jamus, Sweden da kuma The Netherlands) bayar da rahoton wani sabon abu karuwa a psittacosis lokuta a 2023 da kuma a farkon 2024, musamman alama tun Nuwamba-Disamba 2023. Biyar mutuwar. ..
Iloprost, analog na prostacyclin roba da aka yi amfani da shi azaman vasodilator don magance hauhawar jini na huhu (PAH), Hukumar Abinci da Magunguna ta Amurka ta amince da ita don maganin sanyi mai tsanani. Wannan magani ne na farko da aka amince da shi a Amurka don magance...
Juriya na ƙwayoyin cuta musamman ta ƙwayoyin ƙwayoyin cuta na Gram-negative ya kusan haifar da rikici kamar yanayi. Sabon maganin rigakafi Zosurabalpin (RG6006) yana nuna alkawuran. An gano yana da tasiri a kan magungunan ƙwayoyi, Gram-negative kwayoyin CRAB a cikin binciken farko na asibiti. Antimicrobial Juriya (AMR), wanda aka fi sani da...